Ionis Pharmaceuticals, Inc. (IONS) Capital expenditures 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$51.4MFY2025 · since FY2016: $7.1M → $51.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $51.4M | +13.6% |
| FY2024 | $45.3M | +90.2% |
| FY2023 | $23.8M | +51.4% |
| FY2022 | $15.7M | +31.5% |
| FY2021 | $12.0M | -66.0% |
| FY2020 | $35.1M | +13.6% |
| FY2019 | $30.9M | +127.1% |
| FY2018 | $13.6M | -60.9% |
| FY2017 | $34.8M | +389.2% |
| FY2016 | $7.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice